549 an RNA-lipoplex (RNA-LPX) Vaccine Demonstrates Strong Immunogenicity and Promising Clinical Activity in a Phase I Trial in Cutaneous Melanoma Patients with No Evidence of Disease at Trial Inclusion
Regular and Young Investigator Award Abstracts（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined